Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Topas Therapeutics
Biotech
Topas says celiac candidate shines but keeps data under wraps
Topas reported positive phase 2a data on its celiac disease candidate without sharing numbers to validate its upbeat outlook.
Nick Paul Taylor
Oct 15, 2024 8:08am
Sanofi, Pfizer, Acelyrin and more—Chutes & Ladders
May 10, 2024 8:30am
Former Arena CEO takes over new RNA biotech—Chutes & Ladders
May 26, 2023 9:30am
Chutes & Ladders—Five Prime’s COO to succeed founder as CEO
Oct 27, 2017 4:35am
Lilly pens deal for Evotec spinout’s immune tolerance drugs
Aug 22, 2017 10:25am
